Most Favored Nation Agreement and Pricing

Borla describes Pfizer's MFN negotiation, industry-wide pricing changes, and global access implications.

Play episode from 34:31

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!